Lv3
230 积分 2024-05-31 加入
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
1个月前
已完结
Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial
1个月前
已完结
Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4·5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trial
1个月前
已完结
Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes
5个月前
已完结
Approval of Aducanumab for Alzheimer Disease—The FDA’s Perspective
5个月前
已完结
Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial
6个月前
已完结
Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder
6个月前
已完结
Single-Dose Psilocybin Treatment for Major Depressive Disorder
6个月前
已完结
Lecanemab demonstrates highly selective binding to Aβ protofibrils isolated from Alzheimer's disease brains
7个月前
已完结
Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes
7个月前
已完结
皖公网安备34019202002308
